185
Participants
Start Date
June 30, 2021
Primary Completion Date
January 13, 2023
Study Completion Date
August 29, 2023
Upadacitinib
Oral tablets
Placebo
Oral tablets
Virginia Clinical Research, Inc. /ID# 228050, Norfolk
Duplicate_Medical University of South Carolina /ID# 228067, Charleston
CHU Toulouse - Hopital Larrey /ID# 228196, Toulouse
Park Avenue Dermatology, PA /ID# 229400, Orange Park
Duplicate_Hopital Saint-Andre /ID# 228193, Bordeaux
Clearlyderm Dermatology /ID# 227993, Boca Raton
Remington-Davis Clinical Research /ID# 229401, Columbus
Dawes Fretzin, LLC /ID# 227996, Indianapolis
Hamzavi Dermatology /ID# 228056, Fort Gratiot
Duplicate_Michigan Center for Research Company /ID# 228054, Clarkston
HCL - Hopital Edouard Herriot /ID# 228194, Lyon
Bellaire Dermatology Associates /ID# 228004, Bellaire
Duplicate_Hopital Henri Mondor /ID# 228198, Créteil
Stanford University /ID# 228000, Redwood City
Oregon Dermatology and Research Center /ID# 228007, Portland
Oregon Medical Research Center /ID# 228073, Portland
University of California Irvine /ID# 229390, Irvine
New Horizon Research Center /ID# 229403, Miami
ForCare Clinical Research /ID# 228010, Tampa
Tufts Medical Center /ID# 228087, Boston
Duplicate_UMass Chan Medical School /ID# 228066, Worcester
Essential Medical Research, LLC /ID# 228074, Tulsa
International Clinical Research - Tennessee LLC /ID# 228059, Murfreesboro
University of Texas Health Science Center at Houston /ID# 229399, Houston
Dr. Chih-ho Hong Medical Inc. /ID# 228403, Surrey
Wiseman Dermatology Research /ID# 228410, Winnipeg
Research Toronto /ID# 228401, Toronto
Duplicate_K. Papp Clinical Research /ID# 228877, Waterloo
Centre de Recherche dermatologique du Quebec Metropolitain /ID# 228388, Québec
Chu de Nice-Hopital Larchet Ii /Id# 228192, Nice
Nagoya City University Hospital /ID# 228725, Nagoya
Nippon Medical School Hospital /ID# 230361, Bunkyo-ku
Tokyo Medical University Hospital /ID# 230288, Shinjuku-ku
Yamagata University Hospital /ID# 230362, Yamagata
Yamanashi Prefectural Central Hospital /ID# 229441, Kofu
Lead Sponsor
AbbVie
INDUSTRY